Puthupparampil V. Scaria, Ph.D.

Biography

Have extensive experience in the research and development of Nanoparticle delivery technologies for therapeutic and vaccine candidates in academic and industrial environments. Currently heading the Conjugation Development Unit at LMIV to develop new Malaria vaccine candidates employing protein-protein conjugate nanoparticle technology, as well as developing and evaluating new vaccine platforms such as mRNA technology through internal development and external collaborations.